Critical Path Institute (C-Path) is thrilled to announce its Polycystic Kidney Disease Outcomes Consortium (PKDOC) has been awarded an Autosomal Dominant Tubulointerstitial Kidney Disease (ADTKD) ...

Please provide your email address to receive an email when new articles are posted on . From an enrollment of more than 5 million, crude prevalence of autosomal dominant polycystic kidney disease was ...

Please provide your email address to receive an email when new articles are posted on . Tolvaptan treatment correlated with a slowed annual rate of GFR decline in this population. Tolvaptan may ...

Liver cysts were found in over 80% of patients with ADPKD but were not associated with chronic kidney disease stage, Mayo classification, PKD1 or PKD2 genotype variant, liver enzyme levels, or quality ...